if they don't get it what are the options. further dilution to fund FDA tests. think they might find it hard to get the cash even though I think the Yanks would be a lot more open to the nature of the device.
or the Asian markets. diabetes is an increasing issue but still not the problem it is in the west.
maybe the oral is so they can raise the ill considered comments of our chair which were unfortunately picked up and printed by a journo. lol.
still I remain very positive. the main thing the product has in its favour is that it will be a net saver for health budgets.
TIS Price at posting:
18.5¢ Sentiment: Hold Disclosure: Held
